(Reuters) -The U.S. Food and Drug Administration is probing the death of a patient who developed harmful antibodies after taking Takeda Pharmaceuticals' blood disorder therapy, the health regulator said on Friday.
The pediatric patient died about 10 months after starting Takeda's drug Adzynma as a preventive therapy, the agency said.
The child had congenital thrombotic thrombocytopenic purpura (cTTP), an inherited condition that causes blood clots in small vessels and can lead to organ damage.
The FDA said the child developed antibodies that blocked the activity of ADAMTS13, an enzyme critical for blood clotting.
Takeda did not immediately respond to Reuters request for comment.
Adzynma, approved in 2023 as the first therapy for cTTP, replaces the ADAMTS13 protein to help prevent dangerous blood clots.
The agency added it has received multiple postmarketing reports of patients developing neutralizing antibodies to ADAMTS13 after treatment with Adzynma.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Map shows more than 1,900 measles cases across U.S. - 2Toyota’s Next Big Sports Car Might Apparently Be a Turbocharged All-Paw Beast
- 3Family Matters: Tips and Guidance for Effective Nurturing and Everyday Life
- 4Miley Cyrus flashes a diamond ring on the red carpet, sparking engagement rumors with Maxx Morando: A timeline of their four-year relationship
- 5Picking Childcare Administrations for Your Loved ones
- Vote In favor of Your Number one Game Control center
- Remains of banker missing since 1999 found on California beach by family looking for seashells
- Presenting Nintendo's New Pastel Satisfaction Con Tones for Switch Gamers: 3 Upscale Choices
- Collins Foods to offload 20 Taco Bell outlets in Australia
- Journalists killed by Israeli strike in southern Lebanon
- The most effective method to Use an Internet Showcasing Degree for Advanced Predominance
- Which Switch Game Do You Suggest? Share Your Decision
- Starfront Observatories: A haven for distant stargazers
- Philippines evacuates 3,000 villagers after volcano activity raises alert level
